BIOMAT Database Logo BIOMAT Database Logo

[Secondary drug resistance of Mycobacterium tuberculosis in chronic destructive forms of pulmonary tuberculosis]. 1977

A N Poliakova, and O M Ianovskaia, and I D Samuliak, and G V Vasilik, and V M Matviĭchuk

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

A N Poliakova, and O M Ianovskaia, and I D Samuliak, and G V Vasilik, and V M Matviĭchuk
[Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
October 1980, Problemy tuberkuleza,
A N Poliakova, and O M Ianovskaia, and I D Samuliak, and G V Vasilik, and V M Matviĭchuk
[The clinical importance of the primary drug resistance of Mycobacterium tuberculosis in destructive forms of pulmonary tuberculosis].
January 1972, Problemy tuberkuleza,
A N Poliakova, and O M Ianovskaia, and I D Samuliak, and G V Vasilik, and V M Matviĭchuk
[L-forms of Mycobacterium tuberculosis during chemotherapy of patients with chronic destructive pulmonary tuberculosis].
July 1983, Problemy tuberkuleza,
A N Poliakova, and O M Ianovskaia, and I D Samuliak, and G V Vasilik, and V M Matviĭchuk
[Secondary drug resistance of Mycobacterium tuberculosis in coniotuberculosis and pulmonary tuberculosis].
July 1976, Problemy tuberkuleza,
A N Poliakova, and O M Ianovskaia, and I D Samuliak, and G V Vasilik, and V M Matviĭchuk
[Clinical and bacteriological aspects of the drug resistance of Mycobacterium tuberculosis in patients with chronic destructive pulmonary tuberculosis].
January 1986, Problemy tuberkuleza,
A N Poliakova, and O M Ianovskaia, and I D Samuliak, and G V Vasilik, and V M Matviĭchuk
[Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
January 2009, Problemy tuberkuleza i boleznei legkikh,
A N Poliakova, and O M Ianovskaia, and I D Samuliak, and G V Vasilik, and V M Matviĭchuk
[Methods for overcoming drug resistance in destructive and progressive forms of pulmonary tuberculosis].
January 2001, Problemy tuberkuleza,
A N Poliakova, and O M Ianovskaia, and I D Samuliak, and G V Vasilik, and V M Matviĭchuk
[Chronic destructive forms of pulmonary tuberculosis in young persons].
January 1973, Problemy tuberkuleza,
A N Poliakova, and O M Ianovskaia, and I D Samuliak, and G V Vasilik, and V M Matviĭchuk
[Intermittent therapy of chronic destructive forms of pulmonary tuberculosis].
August 1980, Vrachebnoe delo,
A N Poliakova, and O M Ianovskaia, and I D Samuliak, and G V Vasilik, and V M Matviĭchuk
[Primary drug resistance of Mycobacterium tuberculosis in pulmonary tuberculosis].
January 1971, Problemy tuberkuleza,
Copied contents to your clipboard!